Business
HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson
Southlake, TX, May 08, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that it will host a live investor webinar on Wednesday, May 14, 2025, at 2:00 p.m. EDT | 11:00 a.m. PDT, featuring a presentation and Q&A session with CEO Andrew Simpson. Register Now To attend the webinar an
About this update from Heartsciences Inc.
[{"type":"image","alt":"Heart Test Laboratories, Inc.","displaySize":"","headline":null,"caption":"Heart Test Laboratories, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":271,"height":58,"url":"https://media.zenfs.com/en/globenewswire.com/bb8c6c7931166e53de866ed1f7dbdc1d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/TQBZp3ueg1_7du_2jEqWig--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTkwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/bb8c6c7931166e53de866ed1f7dbdc1d","width":271,"height":58}},"lazy":false},{"type":"text","content":"Southlake, TX, May 08, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that it will host a live investor webinar on Wednesday, May 14, 2025, at 2:00 p.m. EDT | 11:00 a.m. PDT, featuring a presentation and Q&A session with CEO Andrew Simpson.","length":486,"tagName":"p"},{"type":"text","content":"Register Now To attend the webinar and participate in the live Q&A, please register through:","length":97,"tagName":"p"},{"type":"text","content":"HeartSciences Investor Webinar May 14th at 2:00 pm EDT","length":54,"tagName":"p"},{"type":"text","content":"This is an opportunity for investors to gain insight into HeartSciences’ mission, market opportunity, and its AI-ECG platform, which is designed to significantly enhance the diagnostic utility of the standard ECG. The platform aims to help clinicians detect heart disease earlier, faster, and at the point of care. CEO Andrew Simpson will also discuss the Company’s current Regulation A investment opportunity, which offers qualified investors access to investment in the Company on terms typically not available through public markets.","length":536,"tagName":"p"},{"type":"text","content":"About HeartSciences","length":19,"tagName":"p"},{"type":"text","content":"HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG’s clinical utility. Millions of ECGs are performed every week and the Company's objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in fro...